Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection

Experimental and Molecular Medicine

Volumn 42, Issue 1, 2010, Pages 69-79

  Lee, Jie Young ^a   Kim, Jung Hwan ^a   Chae, Gibong ^a   Lee, Bong Ki ^a   Ha, Kwon Soo ^a   Kwon, Young Geun ^b   Kim, Young Myeong ^a  

^a Kangwon National University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Apoptosis; Cyclic AMP; Cytokines; Graft rejections; Heart transplantation; Inflammation; Nitric oxide

Indexed keywords

BIOCHEMICAL MARKER; BUCLADESINE; CASPASE 3; CELL ADHESION MOLECULE; CYCLIC AMP; DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; NITRIC OXIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME ACTIVATION; GENE EXPRESSION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; ISOGRAFT; MALE; NITROSYLATION; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL TIME;

ANIMALIA; MURINAE; RATTUS;

EID: 76749094718     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2010.42.1.008     Document Type: Article

References (44)

1. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993;91:2314-9.
2. Cai B, Roy DK, Sciacca R, Michler RE, Cannon PJ. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection. Int J Cardiol 1995;50:243-51
3. Demetris AJ, Murase N, Ye Q, Galvao FHF, Richert C, Saad R, Pham S, Duquesnoy R, Zeevi A, Fung JJ, Starzl TE. Obliterative arteriopathy and Quilty lesions: leukocyte trafficking, microchimerism and the immunolymphatic theory of chronic rejection. Am J Pathol 1997;150:563-78
4. Furukawa Y, Matsumori A, Hirozane T, Matsui S, Sato Y, Ono K, Sasayama S. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and in vitro. Clin Immunol Immunopathol 1996;79:25-35
5. Hanna AK, Miller J, Liang BT, DiSesa VJ. Reversible contractile dysfunction in reversible experimental cardiac allograft rejection: alterations in the beta-receptor-stimulated adenylylcyclase pathway. J Surg Res 1993;54:610-5
6. Hertz MI, Boucek MM, Deng MC, Edwards LB, Keck BM, Kirklin JK, Naftel DC, Rowe AW, Taylor DO, Trulock EP. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2005 annual reports. J Heart Lung Transplant 2005;24:939-44
7. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94
8. Huang WH, Yan Y, De Boer B, Bishop GA, House AK. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts. Transplantation 2003;75:368-74
9. Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, Chun HJ, Liu K, Kim YM, Murase N. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl 2000;6:686-702
10. Ikeda U, Yamamoto K, Ichida M, Ohkawa F, Murata M, Iimura O, Kusano E, Asano Y, Shimada K. Cyclic AMP augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. J Mol Cell Cardiol 1996;28:789-95
11. Josien R, Mu?schen M, Gilbert E, Douillard P, Heslan JM, Soulillou JP, Cuturi MC. Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. Transplantation 1998;66:887-93
12. Kim IK, Bedi DS, Denecke C, Ge X, Tullius SG. Impact of innate and adaptive immunity on rejection and tolerance. Transplantation 2008;86:889-94
13. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-48
14. Kim YM, Chung HT, Simmons RL, Billiar TR. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 2000;275:10954-61
15. -/- recipients correlates with reduced apoptosis. Circulation 1999;99:836-42
16. Kown MH, Van der Steenhoven T, Blankenberg FG, Hoyt G, Berry GJ, Tait JF, Strauss HW, Robbins RC. Zinc-mediated reduction of apoptosis in cardiac allografts. Circulation 2000;102:III228-32
17. Lácha J, Bushell A, Smetana K, Rossmann P, Pribylová P, Wood K, Malý P. Intercellular cell adhesion molecule-1 and selectin ligands in acute cardiac allograft rejection: a study on gene-deficient mouse models. J Leukoc Biol 2002;71:311-8
18. Lancaster JR Jr, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 1992;267:10994-8
19. Langrehr JM, Murase N, Markus PM, Cai X, Neuhaus P, Schraut W, Simmons RL, Hoffman RA. Nitric oxide production in host-versus-graft graft-versus-host reactions in the rat. J Clin Invest 1992;90:679-83
20. Lattmann T, Hein M, Horber S, Ortmann J, Teixeira MM, Souza DG, Haas E, Tornillo L, Münter K, Vetter W, Barton M. Activation of pro-inflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection: role of endothelin receptor signaling. Am J Transplant 2005;5:1042-9
21. Laugwitz KL, Moretti A, Weig HJ, Gillitzer A, Pinkernell K, Ott T, Pragst I, Stödele C, Seyfarth M, Schömig A, Ungerer M. Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther 2001;12:2051-63
22. Lee SJ, Lee JK, Maeng YS, Kim YM, Kwon YK. Langerhans cell protein 1 (LCP1) binds to PNUTS in the nucleus: implications for this complex in transcriptional regulation. Exp Mol Med 2009;41:189-200
23. J, Yang S, Billiar TR. Cyclic nucleotides suppress tumor necrosis factor alpha-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J Biol Chem 2000;275:13026-34
24. Messmer UK, Reimer DM, Brüne B. Protease activation during nitric oxide-induced apoptosis: comparison between poly(ADP-ribose) polymerase and U1-70kDa cleavage. Eur J Pharmacol 1998;349:333-43
25. Murase N, Kim DG, Todo S, Cramer DV, Fung JJ, Starzl TE. Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation 1990;50:186-9
26. Mustafa SB, Olson MS. Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J Biol Chem 1998;273:5073-80
27. Nakanishi AL, Roza AM, Adams MB, Seibel R, Moore-Hilton G, Kalyanaraman B, Pieper GM. Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centered complexes in allogeneic, heterotopic cardiac transplants: effects of treatment with pyrrolidine dithiocarbamate. Free Radic Biol Med 1998;25:201-7
28. Ollivier V, Parry GC, Cobb RR, de Prost D, Mackman N. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 1996;271:20828-35
29. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-9
30. Pahan K, Namboodiri AM, Sheikh FG, Smith BT, Singh I. Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem 1997;272:7786-91
31. Pieper GM, Halligan NL, Hilton G, Konorev EA, Felix CC, Roza AM, Adams MB, Griffith OW. Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection. Proc Natl Acad Sci USA 2003;100:3125-30
32. Pober JS, Slowik MR, De Luca LG, Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993;150:5114-23
33. Rahman A, Anwar KN, Minhajuddin M, Bijli KM, Javaid K, True AL, Malik AB. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-κB activation and ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004;287:1017-24
34. Russell ME, Wallace AF, Hancock WW, Sayegh MH, Adams DH, Sibinga NE, Wyner LR, Karnovsky MJ. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995;59: 572-8
35. Schrepfer S, Deuse T, Schäfer H, Reichenspurner H. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival. Transpl Int 2005;18:215-20
36. Song G, Zhao X, Xu J, Song H. Increased expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in rat cardiac allografts. Transplant Proc 2008;40:2720-3
37. Steinman TI, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN, Wilkinson AH. Clinical Practice Committee, American Society of Transplantation. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 2001;71:1189-204
38. Swenson JM, Fricker FJ, Armitage JM. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506. J Am Coll Cardiol 1995;25:1183-8
39. Szabolcs M, Michler RE, Yang X, Aji W, Roy D, Athan E, Sciacca RR, Minanov OP, Cannon PJ. Apoptosis of cardiac myocytes during cardiac allograft rejection: relation to induction of nitric oxide synthase. Circulation 1996;94:1665-73
40. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801-9
41. Thornberry NA, Lazebnik Y. Caspases, enemies within. Science. 1998;281:1312-6
42. Winlaw DS, Schyvens CG, Smythe GA, Du ZY, Rainer SP, Lord RS, Spratt PM, Macdonald PS. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. Transplantation 1995;60:77-82
43. Worrall NK, Misko TP, Sullivan PM, Hui JJ, Ferguson TB Jr. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection. Ann Thorac Surg 1996;62:378-85
44. Yang X, Chowdhury N, Cai B, Brett J, Marboe C, Sciacca RR, Michler RE, Cannon PJ. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994;94:714-21